Heavy snoring is a risk factor for case fatality and poor short-term prognosis after a first acute myocardial infarction

Sleep

Volumn 31, Issue 6, 2008, Pages 801-807

  Janszky, Imre ^a,b,f   Ljung, Rickard ^a,c   Rohani, Morteza ^d   Hallqvist, Johan ^a,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c CENTRE FOR EPIDEMIOLOGY   (Sweden)

^d Stockholm Heart Center   (Sweden)

^e Stockholm Centre of Public Health   (Sweden)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute myocardial infarction; Case fatality; Prognosis; Sleep disordered breathing; Snoring

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ACUTE HEART INFARCTION; ADULT; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; FATALITY; FEMALE; FOLLOW UP; HAZARD RATIO; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPERTENSION; IMMOBILIZATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SELF REPORT; SMOKING; SNORING;

EID: 44949121038     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/31.6.801     Document Type: Article

References (44)

1. Koskenvuo M, Kaprio J, Partinen M, Langinvainio H, Sarna S, Heikkila K. Snoring as a risk factor for hypertension and angina pectoris. Lancet 1985;1:893-6.
2. Koskenvuo M, Kaprio J, Telakivi T, Partinen M, Heikkila K, Sarna S. Snoring as a risk factor for ischaemic heart disease and stroke in men. Br Med J (Clin Res Ed) 1987;294:16-9.
3. Hu FB, Willett WC, Manson JE, et al. Snoring and risk of cardiovascular disease in women. J Am Coll Cardiol 2000;35:308-13.
4. D'Alessandro R, Magelli C, Gamberini G, et al. Snoring every night as a risk factor for myocardial infarction: a case-control study. BMJ 1990;300:1557-8.
5. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005;353:2034-41.
6. Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U. Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med 2001;164:1910-3.
7. Zamarron C, Gude F, Otero Otero Y, Rodriguez-Suarez JR. Snoring and myocardial infarction: a 4-year follow-up study. Respir Med 1999;93:108-12.
8. Lindberg E, Janson C, Svardsudd K, Gislason T, Hetta J, Boman G. Increased mortality among sleepy snorers: a prospective population based study. Thorax 1998;53:631-7.
9. Leineweber C, Kecklund G, Janszky I, Akerstedt T, Orth-Gomer K. Snoring and progression of coronary artery disease: The Stockholm Female Coronary Angiography Study. Sleep 2004;27:1344-9.
10. Waller PC, Bhopal RS. Is snoring a cause of vascular disease? An epidemiological review. Lancet 1989;1:143-6.
11. Dalmasso F, Prota R. Snoring: analysis, measurement, clinical implications and applications. Eur Respir J 1996;9:146-59.
12. Young T, Finn L, Hla KM, Morgan B, Palta M. Snoring as part of a dose-response relationship between sleep-disordered breathing and blood pressure. Sleep 1996;19:S202-5.
13. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-5.
14. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-84.
15. McNicholas WT, Bonsigore MR. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007;29:156-78.
16. Shin C, Kim J, Kim J, et al. Association of habitual snoring with glucose and insulin metabolism in nonobese Korean adult men. Am J Respir Crit Care Med 2005;171:287-91.
17. Tan KC, Chow WS, Lam JC, et al. HDL dysfunction in obstructive sleep apnea. Atherosclerosis 2006;184:377-82.
18. Larkin EK, Rosen CL, Kirchner HL, et al. Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration. Circulation 2005;111:1978-84.
19. Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002;105:2462-4.
20. von Kanel R, Dimsdale JE. Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease. Chest 2003;124:1956-67.
21. Kato M, Roberts-Thomson P, Phillips BG, et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000;102:2607-10.
22. Leineweber C, Kecklund G, Janszky I, Akerstedt T, Orth-Gomer K. Poor sleep increases the prospective risk for recurrent events in middle-aged women with coronary disease. The Stockholm Female Coronary Risk Study. J Psychosom Res 2003;54:121-7.
23. Marin JM, Carrizo SJ, Kogan I. Obstructive sleep apnea and acute myocardial infarction: clinical implications of the association. Sleep 1998;21:809-15.
24. Peker Y, Hedner J, Kraiczi H, Loth S. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000;162:81-6.
25. Reuterwall C, Hallqvist J, Ahlbom A, et al. Higher relative, but lower absolute risks of myocardial infarction in women than in men: analysis of some major risk factors in the SHEEP study. The SHEEP Study Group. J Intern Med 1999;246:161-74.
26. Linnersjo A, Hammar N, Gustavsson A, Reuterwall C. Recent time trends in acute myocardial infarction in Stockholm, Sweden. Int J Cardiol 2000;76:17-21.
27. Killip T 3rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 1967;20:457-64.
28. Hammar N, Nerbrand C, Ahlmark G, et al. Identification of cases of myocardial infarction: hospital discharge data and mortality data compared to myocardial infarction community registers. Int J Epidemiol 1991;20:114-20.
29. Rosen M. National Health Data Registers: a Nordic heritage to public health. Scand J Public Health. 2002:81-5.
30. Schaufelberger M SK, Koster M, Rosen M, Rosengren A. Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000. European Heart Journal 2004:300-7.
31. Ingelsson E, Arnlov J, Sundstrom J, Lind L. The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail 2005;7:787-91.
32. Milleron O, Pilliere R, Foucher A, et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 2004;25:728-34.
33. Hagenah GC, Gueven E, Andreas S. Influence of obstructive sleep apnoea in coronary artery disease: A 10-year follow-up. Respir Med 2006;100:180-2.
34. Franklin KA, Nilsson JB, Sahlin C, Naslund U. Sleep apnoea and nocturnal angina. Lancet 1995;345:1085-7.
35. Koehler U, Fus E, Grimm W, et al. Heart block in patients with obstructive sleep apnoea: pathogenetic factors and effects of treatment. Eur Respir J 1998;11:434-9.
36. Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 2006;173:910-6.
37. Doherty LS, Kiely JL, Swan V, McNicholas WT. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005;127:2076-84.
38. Joyeux-Faure M, Stanke-Labesque F, Lefebvre B, et al. Chronic intermittent hypoxia increases infarction in the isolated rat heart. J Appl Physiol 2005;98:1691-6.
39. Seppala T, Partinen M, Penttila A, Aspholm R, Tiainen E, Kaukianen A. Sudden death and sleeping history among Finnish men. J Intern Med 1991;229:23-8.
40. Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005;352:1206-14.
41. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53.
42. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002;359:204-10.
43. Hoffstein V, Rubinstein I, Mateika S, Slutsky AS. Determinants of blood pressure in snorers. Lancet 1988;2:992-4.
44. Telakivi T, Partinen M, Koskenvuo M, Salmi T, Kaprio J. Periodic breathing and hypoxia in snorers and controls: validation of snoring history and association with blood pressure and obesity. Acta Neurol Scand 1987;76:69-75.